Wow! ⁦ASBrS⁩ Friday am opening session is packed. Record setting attendance again! #lifelonglearning #ASBrS24

Danielle Thompson, MD controlling large rooms at #asbrs24 discussing patient perceptions of time delays in breast cancer diagnosis and treatment. Very proud of you Dr. Thompson. 💐UChicago Surgery

It has begun! #ASBRS24

Here we go! Can you believe she sifted through 25k papers?Such a valuable session by Dr Helen Pass. ⁦ASBrS⁩ ⁦ #asbrs24

Having fun at the ⁦ASBrS⁩ booth in the exhibit hall! #ASBrS24

Another amazing conference by #ASBRS24 - this year was extra special for me to moderate a session! Coming home with fresh ideas and motivation for all my patients- this is why we travel, network, and continuously learn to be better.

Data from ispy2 shows IM lymphadenopathy in patients treated with neoadjuvant chemotherapy does not negatively impact outcome. #asbrs24 ⁦I-SPY 2⁩ Mara Piltin⁩ ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩

Awesome #ASBrS24 talk by Shawna Willey on our value as surgeons beyond RVUs! Inova Schar Cancer Institute ASBrS

A great end to an awesome day at #ASBrS24 We are lucky to have such inspirational leaders! Judy Boughey Dr. Susan K. Boolbol

Congratulations to winners of the top presentations and poster winners #ASBrS24 !!! ASBrS

Great talk by ⁦Kristin E. Rojas MD, FACS, FACOG⁩ about disparities in oncofertility care ⁦ASBrS⁩ #ASBrS24

Congratulations to superstar Terry P. Gao on an elegant analysis and beautiful presentation of data showing that reimbursements for breast surgeons are not keeping pace with inflation. 👏🏻👏🏻 #ASBRS24 ASBrS TUHS Dept of Surgery

Great work presented by our Mayo Clinic fellows and residents at #ASBRS24

Judy Boughey
Tina J Hieken MD

Great study using REQUITE database for QoL outcomes for women over 70 with breast cancer: choice of endocrine therapy matters ⁦ASBrS⁩ #ASBrS24

Look what I got to take home with me! Thanks Julie Margenthaler!
See you next year!
#ASBRS24

Great talk about de-escalation of DCIS treatment using the 7 gene DCIS biosignature to follow up on her “Great Debate”. Julie Margenthaler ASBrS #ASBrS24

For large or multiple breast lesions, oncoplastic BCS is associated with decreased cost, fewer surgeries and complications, shorter time to completion of surgical therapy and similarly excellent cosmesis compared to mastectomies. Janelle Millen Janie Grumley, MD Donald L. Morton CGSO Fellowship Program #asbrs24

And that’s a wrap for #ASBrS24 ! Thank you Jennifer Gass for organizing such a phenomenal meeting! Can’t wait to see everyone in Vegas next year!!! ASBrS

Great posters from ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ presented at #asbrs24 last night. ⁦Tina J Hieken MD⁩

Thanks to Theresa Schwartz MD MS FACS for a great overview on rare breast tumors!
#ASBRS24